[10th International Conference on Behçet Syndrome. Berlin, June 27-29, 2002]

Rev Med Interne. 2002 Oct;23(10):808-9. doi: 10.1016/s0248-8663(02)00705-1.
[Article in French]
No abstract available

Publication types

  • Congress

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / drug therapy
  • Behcet Syndrome* / genetics
  • Berlin
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Receptors, Tumor Necrosis Factor / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept